Avadel Pharmaceuticals PLC (AVDL) Insider Trading
- $6,405,735.09
- $7,558,538.08
- Jan. 16, 2024
- Craig R Stapleton
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 16, 2024 | CFO | 2,000 | $14.50 | Buy | $29,000.00 | |
| Dec. 28, 2023 | Director | 75,000 | $14.53 | Sell | $1,089,750.00 | |
| Aug. 14, 2023 | CFO | 2,000 | $14.45 | Buy | $28,900.00 | |
| Aug. 10, 2023 | CEO | 10,000 | $13.20 | Buy | $132,000.00 | |
| Aug. 10, 2023 | Director | 14,000 | $13.40 | Buy | $187,600.00 | |
| May 9, 2023 | Director | 2,500 | $14.76 | Buy | $36,900.00 | |
| Dec. 23, 2022 | Director | 2,000 | $7.20 | Buy | $14,400.00 | |
| Nov. 29, 2022 | CFO | 5,000 | $7.80 | Buy | $39,000.00 | |
| May 31, 2022 | Director | 15,000 | $2.16 | Buy | $32,400.00 | |
| May 27, 2022 | CFO | 50,000 | $2.14 | Buy | $107,000.00 | |
| May 27, 2022 | Director | 10,000 | $1.60 | Buy | $16,000.00 | |
| Sept. 18, 2020 | CFO | 4,000 | $6.00 | Buy | $24,000.00 | |
| Sept. 16, 2020 | Director | 118,602 | $5.73 | Buy | $679,589.46 | |
| Aug. 14, 2020 | Director | 2,500 | $7.94 | Buy | $19,850.00 | |
| Aug. 13, 2020 | CFO | 10,000 | $7.78 | Buy | $77,800.00 | |
| Aug. 12, 2020 | Director | 15,000 | $7.76 | Buy | $116,400.00 | |
| Aug. 12, 2020 | CEO | 13,000 | $7.78 | Buy | $101,140.00 | |
| Dec. 12, 2019 | Insider | 3,072 | $7.23 | Sell | $22,210.56 | |
| Dec. 4, 2019 | Director | 10,000 | $5.76 | Buy | $57,600.00 | |
| Nov. 18, 2019 | Director | 20,000 | $5.30 | Buy | $106,000.00 | |
| Nov. 15, 2019 | Director | 10,000 | $5.32 | Buy | $53,200.00 | |
| Nov. 15, 2019 | CEO | 19,000 | $5.32 | Buy | $101,080.00 | |
| Dec. 14, 2018 | Insider | 3,173 | $2.58 | Sell | $8,186.34 | |
| Aug. 10, 2018 | CEO | 16,297 | $4.91 | Sell | $80,018.27 | |
| Aug. 10, 2018 | Insider | 6,290 | $4.91 | Sell | $30,883.90 | |
| June 26, 2018 | CEO | 2,500 | $6.04 | Buy | $15,100.00 | |
| June 25, 2018 | Insider | 114,034 | $5.99 | Sell | $683,063.66 | |
| May 24, 2018 | CEO | 3,000 | $6.44 | Buy | $19,320.00 | |
| Dec. 15, 2017 | Director | 140,000 | $8.67 | Buy | $1,213,800.00 | |
| Dec. 7, 2017 | CEO | 5,000 | $8.86 | Buy | $44,300.00 | |
| Nov. 27, 2017 | Director | 254,265 | $9.35 | Sell | $2,377,377.75 | |
| Sept. 21, 2017 | Director | 5,155 | $9.74 | Buy | $50,209.70 | |
| Sept. 14, 2017 | Insider | 2,100 | $9.36 | Buy | $19,656.00 | |
| Sept. 13, 2017 | Insider | 5,000 | $9.36 | Buy | $46,800.00 | |
| Sept. 12, 2017 | Director | 20,000 | $9.52 | Buy | $190,400.00 | |
| Sept. 12, 2017 | Insider | 10,600 | $9.32 | Buy | $98,792.00 | |
| Sept. 12, 2017 | CEO | 4,000 | $9.80 | Buy | $39,200.00 | |
| June 23, 2017 | Major Shareholder | 261,000 | $10.68 | Sell | $2,787,480.00 | |
| June 15, 2017 | Director | 26,560 | $10.46 | Sell | $277,817.60 | |
| May 22, 2017 | Director | 31,013 | $9.85 | Buy | $305,478.05 | |
| May 19, 2017 | CEO | 2,500 | $10.00 | Buy | $25,000.00 | |
| Nov. 29, 2016 | Director | 20,000 | $10.79 | Buy | $215,800.00 | |
| Nov. 21, 2016 | CEO | 2,000 | $10.64 | Buy | $21,280.00 | |
| Sept. 22, 2016 | Director | 15,000 | $13.45 | Sell | $201,750.00 | |
| Sept. 2, 2016 | CEO | 2,000 | $14.12 | Buy | $28,240.00 | |
| Sept. 1, 2016 | Director | 10,000 | $13.52 | Buy | $135,200.00 | |
| Aug. 26, 2016 | Director | 20,000 | $13.76 | Buy | $275,200.00 | |
| Aug. 22, 2016 | CEO | 5,000 | $14.30 | Buy | $71,500.00 | |
| May 16, 2016 | Director | 27,228 | $9.21 | Buy | $250,769.88 | |
| May 12, 2016 | CEO | 5,000 | $8.84 | Buy | $44,200.00 |
Insiders are both buying and selling Avadel Pharmaceuticals PLC stock.
The insider traders at Avadel Pharmaceuticals PLC are: Craig R Stapleton, Michael S. Anderson, Thomas S Mchugh, Michael S Anderson, Linda Palczuk, Sandra L. Hatten, Eric J Ende, Mark Anthony Mccamish, Geoffrey Michael Glass, Greg J Divis, Sandra L Hatten, Healthcare Master Fun Broadfin, Francis Fildes, Guillaume Cerutti, Eric J. Ende, Peter J Thornton, Phillandas T Thompson, Phillandas T. Thompson, Gregory J Divis, Gregory J. Divis, and James E. Flynn
The most active insider trader at Avadel Pharmaceuticals PLC is Craig R Stapleton with 9 trades.
Healthcare Master Fun Broadfin has sold the most Avadel Pharmaceuticals PLC stock with a total value of $5,574,960.00.
Craig R Stapleton has bought the most Avadel Pharmaceuticals PLC stock with a total value of $4,839,447.93.
The most recent insider trade for Avadel Pharmaceuticals PLC was on Jan. 16, 2024.
The single biggest insider buy for Avadel Pharmaceuticals PLC was from Craig R Stapleton with a total value of $1,213,800.00 on Dec. 15, 2017.
The single biggest insider sell for Avadel Pharmaceuticals PLC was from Healthcare Master Fun Broadfin with a total value of $2,787,480.00 on June 23, 2017.